$33.21
0.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 11
Data gathered: December 11
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 21 0% |
|
| Sentiment | 65 0% |
|
| Webpage traffic | 32,000 -48.3% |
|
| Employee Rating | 67 0% |
|
| Google Adspend | $72 N/A | N/A |
| Google Trends | 17 0% |
|
| Linkedin Employees | 251 N/A |
|
| Patents | 49 0% |
|
| 4chan Mentions | 0% | N/A |
| Facebook Engagement | 2 0% |
|
| Facebook followers | 1,127 0% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 661 0% |
|
| Twitter Followers | 777 0% |
|
| Instagram Followers | 111 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 82 0% |
|
In the news
 |
Crinetics Pharmaceuticals (NASDAQ:CRNX) Earns Overweight Rating from Cantor FitzgeraldDecember 7 - ETF Daily News |
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Crinetics Pharmaceuticals (CRNX) and IGM Biosciences (IGMS)December 5 - TipRanks |
|
 |
12 Stocks Billionaire Steve Cohen Just Bought and SoldDecember 2 - Yahoo |
Crinetics participates in a conference call with Cantor FitzgeraldNovember 30 - Thefly.com |
|
 |
Crinetics Pharmaceuticals: Some Caution WarrantedNovember 27 - SeekingAlpha |
JP Morgan bullish on six Big Biotechs, rates nine others neutral or lowerNovember 24 - Seeking Alpha |
|
About Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for endocrine diseases and endocrine-related tumors.
| Price | $33.21 |
| Target Price | Sign up |
| Market Cap | $2.22B |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 350,000 | 15M | -15M | -57M | -59M |
| Q2 '23 | 990,000 | 13M | -12M | -51M | -53M |
| Q1 '23 | 2.7M | 12M | -9.8M | -46M | -48M |
| Q4 '22 | 1.7M | 12M | -9.8M | -45M | -47M |
| Q3 '22 | 460,000 | 12M | -11M | -42M | -43M |
Insider Transactions
| Betz Stephen F. filed to sell 85,298 shares at $31.8. November 29 '23 |
| Struthers Richard Scott filed to sell 135,522 shares at $30.6. November 6 '23 |
| Wilson Marc filed to sell 95,601 shares at $28.8. November 3 '23 |
| Krasner Alan Seth filed to sell 43,210 shares at $30. October 19 '23 |
| Struthers Richard Scott filed to sell 630,805 shares at $20.4. July 13 '23 |
Read more about Crinetics Pharmaceuticals and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.